IL2 and hemophilia A: Our previous studies using IL-2/IL-2mAb complexes alone showed five to sevenfold expansion of highly suppressive Treg cells in vivo, which induced long-term tolerance to FVIII in unprimed hemophilia A mice following gene therapy (24).